Generics
Lupin announces US launch of Azilsartan Medoxomil Tablets
18 June 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Thursday the launch of Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States fol...
Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz
5 June 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes, and sells generic medicines in the United States, announced on Thursday th...
Hims & Hers expands GLP-1 offering in Canada with generic semaglutide
21 May 2026 - Health and wellness platform Hims & Hers Health Inc (NYSE:HIMS) announced on Thursday that it has launched access to generic semaglutide through its platform in Canada, marking its f...
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
15 May 2026 - Apotex Inc, a Canada-based global health company, announced on Thursday the commercial launch in Canada of Apo-Semaglutide Injection, a generic equivalent of Ozempic.The product will be ...
Transpire Bio's generic high-strength Trelegy Ellipta ANDA accepted for filing by US FDA
12 May 2026 - Clinical-stage biopharmaceutical company Transpire Bio Inc announced on Monday that its abbreviated new drug application (ANDA) for fluticasone furoate, umeclidinium, and vilanterol inha...
Kaiser Permanente reports study findings showing significant cost savings
7 May 2026 - Health care provider Kaiser Permanente said on Wednesday that it has commissioned Milliman, a global actuarial and professional services consulting firm, to conduct a study comparing Kais...